Your browser doesn't support javascript.
loading
An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study.
Peremiquel-Trillas, Paula; Paytubi, Sonia; Pelegrina, Beatriz; Frias-Gomez, Jon; Carmona, Álvaro; Martínez, José Manuel; de Francisco, Javier; Benavente, Yolanda; Barahona, Marc; Briansó, Ferran; Canet-Hermida, Júlia; Caño, Víctor; Vidal, August; Zanca, Alba; Baixeras, Núria; Rodríguez, Axel; Fernández-Gonzalez, Sergi; Dueñas, Núria; Càrdenas, Laura; Aytés, Álvaro; Bianchi, Ilaria; Pavón, Miquel Àngel; Reventós, Jaume; Capellà, Gabriel; Gómez, David; Diaz, Mireia; Ponce, Jordi; Brunet, Joan; Matias-Guiu, Xavier; Bosch, Francesc Xavier; de Sanjosé, Silvia; Alemany, Laia; Pineda, Marta; Marin, Fátima; Costas, Laura.
Afiliación
  • Peremiquel-Trillas P; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Paytubi S; Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain.
  • Pelegrina B; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Frias-Gomez J; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Carmona Á; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Martínez JM; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • de Francisco J; Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain.
  • Benavente Y; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Barahona M; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Briansó F; Department of Gynecology, IDIBELL, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Canet-Hermida J; Department of Anesthesiology, IDIBELL, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Caño V; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Vidal A; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Zanca A; Department of Gynecology, IDIBELL, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Baixeras N; Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, 08028 Barcelona, Spain.
  • Rodríguez A; Roche Diagnostics, Sant Cugat del Vallès, 08174 Barcelona, Spain.
  • Fernández-Gonzalez S; Hereditary Cancer Group, ONCOBELL Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, 08908 Barcelona, Spain.
  • Dueñas N; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Càrdenas L; Department of Anesthesiology, IDIBELL, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Aytés Á; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Bianchi I; Department of Pathology, IDIBELL, Hospitalet de Llobregat, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
  • Pavón MÀ; Department of Pathology, IDIBELL, Hospitalet de Llobregat, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
  • Reventós J; Department of Pathology, IDIBELL, Hospitalet de Llobregat, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
  • Capellà G; Department of Pathology, IDIBELL, Hospitalet de Llobregat, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
  • Gómez D; Department of Gynecology, IDIBELL, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Diaz M; Hereditary Cancer Group, ONCOBELL Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, 08908 Barcelona, Spain.
  • Ponce J; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Brunet J; Department of Gynecology and Obstetrics, Hospital Universitari Dr. Josep Trueta, 17007 Girona, Spain.
  • Matias-Guiu X; Program against Cancer Therapeutic Resistance (ProCURE), IDIBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Bosch FX; ASSIR Delta, Serveis d'Atenció Primària Delta del Llobregat, Direcció d'Atenció Primària Costa de Ponent, Gerència Territorial Metropolitana Sud, Institut Català de la Salut, 08006 Barcelona, Spain.
  • de Sanjosé S; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, IDIBELL, l'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Alemany L; Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, 28029 Madrid, Spain.
  • Pineda M; Departament de Ciències Bàsiques, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.
  • Marin F; Hereditary Cancer Group, ONCOBELL Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, 08908 Barcelona, Spain.
  • Costas L; Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health, 28029 Madrid, Spain.
J Pers Med ; 12(7)2022 Jun 29.
Article en En | MEDLINE | ID: mdl-35887570
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: España